Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

SABCS 2020 and Sabcs 2020 View overview page

1:01
Future of breast cancer care: HER2 therapies in earlier settings & de-escalation
Sibylle Loibl • 10 Dec 2020
1:17
Future advances in DCIS: de-escalation of hormonal therapy
Ivana Sestak • 10 Dec 2020
6:45
Innovative biomarker approaches in breast cancer therapy
Christos Sotiriou • 27 Nov 2020
3:01
ALTERNATE: neoadjuvant chemotherapy in ER+ HER2- breast cancer
Cynthia X. Ma • 3 Dec 2020
3:04
12-year results of anastrozole vs tamoxifen for breast cancer prevention
Ivana Sestak • 10 Dec 2020
5:00
PENELOPE-B: palbociclib with endocrine therapy in HR+, HER2-negative breast cancer
Sibylle Loibl • 10 Dec 2020
5:26
Improving risk prediction and decision making in DCIS patients
Eileen Rakovitch • 27 Nov 2020
2:26
Chances of pregnancy after breast cancer
Matteo Lambertini • 9 Dec 2020
4:25
ASCENT: sacituzumab govitecan shows promise in mTNBC patients
Sara Hurvitz • 30 Nov 2020
2:29
SWOG S9313: classification of TNBC by DNA damage response + homologous recombination deficiency
Shane Stecklein • 8 Dec 2020
2:53
ESMO Clinical Practice Guidelines: fertility preservation & management of post-treatment pregnancies
Matteo Lambertini • 9 Dec 2020
0:29
Upcoming trial updates at SABCS 2020
Shane Stecklein • 9 Dec 2020
4:45
Using AI to improve mammograms in breast cancer screening
Constance Lehman • 4 Dec 2020
2:16
SABCS 2020: monarchE, PENELOPE-B, TAILORx & ASCENT
Matteo Lambertini • 9 Dec 2020
0:54
Using biology to identify best outcomes
Shane Stecklein • 8 Dec 2020
2:49
The role of gut microbiome in breast cancer risk
Timothy Robinson • 1 Dec 2020
The content of VJOncology is intended for healthcare professionals